Position in PFE
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$885,469
-$182,975 QoQ
Shares Held
36,772
-3.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,398
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CENTAURUS FINANCIAL, INC. holds $28,490,833 across 13 Drug Manufacturers - General names. PFE ranks #8 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,081 | $14,490,315 | |
| 2 | ABBV |
AbbVie Inc.
|
13,295 | $3,345,553 | |
| 3 | JNJ |
Johnson & Johnson
|
12,384 | $3,145,164 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,912 | $1,530,692 | |
| 5 | AMGN |
Amgen Inc
|
3,413 | $1,235,915 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,694 | $972,059 | |
| 7 | NVS |
Novartis AG
|
5,748 | $900,826 | |
| 8 | PFE |
Pfizer Inc
This page
|
36,772 | $885,469 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $885,469 | 36,772 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $1,068,444 | 38,050 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $1,008,051 | 40,484 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,231,575 | 48,335 | Shares | Sole | 2025-11-20 | |
| 2025-06-30 | $1,267,630 | 52,295 | Shares | Sole | 2025-08-29 | |
| 2025-03-31 | $1,566,696 | 61,827 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,659,504 | 62,552 | Shares | Sole | 2025-03-12 | |
| 2024-09-30 | $1,867,874 | 64,543 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,746,315 | 62,413 | Shares | Sole | 2024-09-23 | |
| 2024-03-31 | $1,765,122 | 63,608 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,935,753 | 67,237 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $2,166,763 | 65,323 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,439,953 | 66,520 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $3,826,387 | 93,784 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $5,005,840 | 97,694 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,478,442 | 102,341 | Shares | Sole | 2022-12-05 | |
| 2022-06-30 | $5,664,694 | 108,043 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $5,232,290 | 101,068 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,893,650 | 82,873 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $3,524,712 | 81,951 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,332,046 | 85,088 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,115,252 | 58,384 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $1,934,107 | 52,543 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $1,476,109 | 40,221 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,643,928 | 50,273 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,688,464 | 51,730 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||